TR200003737T1 - Diyet takviyesi ya da ilaç olarak kullanılan bileşim - Google Patents

Diyet takviyesi ya da ilaç olarak kullanılan bileşim

Info

Publication number
TR200003737T1
TR200003737T1 TR2000/03737T TR200003737T TR200003737T1 TR 200003737 T1 TR200003737 T1 TR 200003737T1 TR 2000/03737 T TR2000/03737 T TR 2000/03737T TR 200003737 T TR200003737 T TR 200003737T TR 200003737 T1 TR200003737 T1 TR 200003737T1
Authority
TR
Turkey
Prior art keywords
dietary supplement
medicine
composition used
tissue
forms
Prior art date
Application number
TR2000/03737T
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of TR200003737T1 publication Critical patent/TR200003737T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Bu bulusta, kardiyovasküler ve nöro-serebral bozukluklarin, doku anoksik formlarinin, enerjetik kas bozukluklarinin, iltihapli türden anormalliklerin, tromboz gibi kan pihtilasma sorunlarinin ve doku çogalma formlarinin önlenmesi ve/ya da tedavisi için uygun ve bir diyet takviyesi, besin destegi ya da bir ilaç seklinde olabilen bir bilesim tarif edilmektedir ki söz konusu bilesim karakterize edici madde olarak (a) propiyonil L-karnitin ya da bunun ispençiyari olarak kabul edilebilir bir tuzu; ve (b) bir inositol fosfat, özellikle inositol hegzafosfat (IP6) ihtiva eder.
TR2000/03737T 1999-04-22 2000-04-19 Diyet takviyesi ya da ilaç olarak kullanılan bileşim TR200003737T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.

Publications (1)

Publication Number Publication Date
TR200003737T1 true TR200003737T1 (tr) 2001-07-23

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03737T TR200003737T1 (tr) 1999-04-22 2000-04-19 Diyet takviyesi ya da ilaç olarak kullanılan bileşim

Country Status (26)

Country Link
US (1) US6565876B1 (tr)
EP (1) EP1119363B1 (tr)
JP (1) JP2002542282A (tr)
KR (1) KR20010053023A (tr)
CN (1) CN1359295A (tr)
AR (1) AR023391A1 (tr)
AT (1) ATE299370T1 (tr)
AU (1) AU776591B2 (tr)
BR (1) BR0006076A (tr)
CA (1) CA2335015C (tr)
DE (1) DE60021247T2 (tr)
DK (1) DK1119363T3 (tr)
EE (1) EE200000742A (tr)
ES (1) ES2243254T3 (tr)
HU (1) HU227357B1 (tr)
IL (1) IL140164A0 (tr)
IS (1) IS5763A (tr)
IT (1) IT1306133B1 (tr)
NO (1) NO20006429L (tr)
PL (1) PL197885B1 (tr)
PT (1) PT1119363E (tr)
SI (1) SI1119363T1 (tr)
SK (1) SK19322000A3 (tr)
TN (1) TNSN00083A1 (tr)
TR (1) TR200003737T1 (tr)
WO (1) WO2000064426A2 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
DK1863495T3 (en) * 2005-03-18 2015-04-20 Normoxys Inc CALCIUM AND SODIUM SALT OF MYO-INOSITOL 1.6: 2,3: 4,5 TRIPYROPHOSPHATE FOR CANCER TREATMENT
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
MX2011004666A (es) * 2008-11-11 2011-05-31 Sigma Tau Ind Farmaceuti Compuesto util para tratar celulitis.
SG185692A1 (en) * 2010-06-16 2013-01-30 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
WO2020237172A1 (en) * 2019-05-23 2020-11-26 Xinova, LLC Compositions and methods for the treatment and mitigation of alcohol-induced skin flushing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
CA2335015C (en) 2008-03-18
AU4313500A (en) 2000-11-10
SK19322000A3 (sk) 2001-06-11
CA2335015A1 (en) 2000-11-02
AU776591B2 (en) 2004-09-16
HUP0102926A2 (hu) 2002-03-28
ATE299370T1 (de) 2005-07-15
DE60021247T2 (de) 2006-04-27
TNSN00083A1 (fr) 2005-11-10
BR0006076A (pt) 2001-03-20
JP2002542282A (ja) 2002-12-10
EP1119363A2 (en) 2001-08-01
PL197885B1 (pl) 2008-05-30
PT1119363E (pt) 2005-09-30
AR023391A1 (es) 2002-09-04
HU227357B1 (en) 2011-04-28
DE60021247D1 (de) 2005-08-18
EP1119363B1 (en) 2005-07-13
SI1119363T1 (en) 2005-10-31
US6565876B1 (en) 2003-05-20
ES2243254T3 (es) 2005-12-01
WO2000064426A2 (en) 2000-11-02
IT1306133B1 (it) 2001-05-30
IL140164A0 (en) 2002-02-10
WO2000064426A3 (en) 2001-05-25
PL346160A1 (en) 2002-01-28
DK1119363T3 (da) 2005-10-17
CN1359295A (zh) 2002-07-17
IS5763A (is) 2000-12-08
EE200000742A (et) 2002-04-15
NO20006429L (no) 2001-02-20
KR20010053023A (ko) 2001-06-25
HUP0102926A3 (en) 2002-12-28
ITRM990248A1 (it) 2000-10-22
NO20006429D0 (no) 2000-12-15

Similar Documents

Publication Publication Date Title
TR200003737T1 (tr) Diyet takviyesi ya da ilaç olarak kullanılan bileşim
WO2000011968A8 (en) ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
WO2002034072A3 (en) Synergistic antioxidant combination of delta tocols and polyphenols
NO20006431L (no) Sammensetning for å forhindre og/eller behandle osteoporose og forandringer på grunn av menopausalsyndrom
DE69836335D1 (de) Natürliche inhaltsstoffe enthaltende nahrungsergänzungsstoffe
DE60012301D1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
IT1311495B1 (it) Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
TR200200948T2 (tr) L-karnitin türevlerini ve ginkgo biloba özlerini içeren bileşim
GB9613070D0 (en) Dietary lectins
DE60019784D1 (de) Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
MXPA02011465A (es) Sal de creatina que tiene eficacia terapeutica y nutricional mejorada y composiciones que contienen la misma.
WO2000000183A3 (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin
DE69804466T2 (de) Robinia pseudoacacia lektin und seine verwendungen
EP1429723A4 (en) TREATMENT EFFECTS OF EXCESSIVE REACTIVE OXYGEN SPECIES
HK1036203A1 (en) Food supplements comprising lipoic acid and creatine and methods for their use
HUP9803039A2 (hu) Az elhízás kezelésére, megelőzésére, szövődményei kialakulásának kivédésére, a kialakult szövődmények kezelésére szolgáló gyógyászati kompozíció
Di Giulio 4th Basic Multidisciplinary Hemodialysis Access Course
ITRM20010494A0 (it) Integratore dietetico per la cura e la prevenzione della miopia.
ITRM20010493A0 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.
GEU1998374Y (en) Method for Receiving Means for Treatment of Cardiovascular Diseases